Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy

Nursing in Critical Care

Volumn 14, Issue 4, 2009, Pages 191-199

  Tillman, Joanne ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adult intensive care unit; Citrate; Haemofiltration; Heparin; Renal failure

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; HEPARIN;

ACUTE KIDNEY FAILURE; ADULT; COMPARATIVE STUDY; CRITICAL ILLNESS; HEMOFILTRATION; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW;

ADULT; ANTICOAGULANTS; CITRATES; CRITICAL ILLNESS; HEMOFILTRATION; HEPARIN; HUMANS; KIDNEY FAILURE, ACUTE; RENAL REPLACEMENT THERAPY;

EID: 69849106615     PISSN: 13621017     EISSN: 14785153     Source Type: Journal    
DOI: 10.1111/j.1478-5153.2009.00339.x     Document Type: Review

References (28)

1. Bagshaw SM, Laupland KB, Boiteau PJE, Godinez-Luna T. (2005). Is regional citrate superior to heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. Journal of Critical Care; 20: 155–161.
2. Betjes MGH, Oosterom MVA, Wetering J. (2007). Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: Similar hemofilter survival but significantly less bleeding. Journal of Nephrology; 20: 602–608.
3. Brophy PD, Somers MJG, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rodgers K, Barnett J, Blowey D, Baker C, Buchman TE, Goldstien SL. (2005). Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy. Nephrology Dialysis Transplantation; 20: 1416–1421.
4. Embase. (1980-present). http://ovidsp.uk.ovid.com/spb/ovidweb. cgi (accessed 4/04/08).
5. Fealy N, Baldwin I, Johnstone M, Egi M, Bellomo R. (2007). A pilot randomised controlled crossover study comparing regional heparinisation to regional citrate anticoagulation for continuous venovenous hemofiltration. International Journal of Artificial Organs; 30: 301–307.
6. Fiaccadori E, Maggiore U, Rotelli C, Minari M, Melfa L, Cappe G, Cabassi A. (2002). Continuous hemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent. Intensive Care Medicine; 28: 586–593.
7. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C. (2002). Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Medicine; 28: 1419–1425.
8. Greenhalgh T. (2007). How to Read a Paper: The Basics of Evidence Based Medicine, 3rd edn. London: BMJ Publishing.
9. Greenhalgh T, Donald A. (2000). Evidence Based Health Care Workbook: Understanding Research. London: BMJ Books.
10. Griffiths P. (2002). Evidence informing practice: introducing a mini review. British Journal of Community Nursing; 7: 38–40.
11. Haynes RB, Devereaux PJ, Guyatt GH. (2002). Clinical expertise in the era of evidence based medicine and patient choice. Evidence-Based Medicine; 7: 36–38.
12. Kozek-Langenecker SA, Kettner SC, Oismueller C, Gonano C, Speiser W, Zimpfer M. (1998). Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration. Critical Care Medicine; 26: 1208–1212.
13. Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT. (2000). Regional citrate anticoagulation in continuous venovenous hemodiafiltration. American Journal of Kidney Diseases; 35: 802–811.
14. Kutsogiannis DJ, Gibney NRT, Stollery D, Gao J. (2005). Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney International; 67: 2361–2367.
15. Mehta RL, McDonald BR, Aguilar MM, Ward DM. (1990). Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney International; 38: 976–981.
16. Menajovsky LB. (2005). Heparin-induced thrombocytopenia: clinical manifestations and management strategies. American Journal of Medicine; 118: 21–30.
17. Mitchell A, Daul A, Beiderlinden M, Schafers RF, Heemann U, Kribben A, Peters J, Phillipp T, Wenzel RR. (2003). A new system for regional citrate anticoagulation in continuous venovenous hemodialysis. Clinical Nephrology; 59: 106–114.
18. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. (2004). Citrate V’s Heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Medicine; 30: 260–265.
19. Morgera S, Schoole C, Voss G, Hasse M, Vergas-Hein O, Krausch D, Melzer C, Rosseau S, Zuckermann-Becker H, Neumayer HH. (2004). Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis – single centre experience. Nephron Clinical Practice; 97: 131–136.
20. O’Brian PC, Fleming TR. (1979). The multiple testing procedure for clinical trials. Biometrics; 35: 549–556.
21. Ovid Medline. (1950-present). http://ovidsp.uk.ovid.com/spb/ovidweb.cgi (accessed 10/04/08).
22. Oudemans-van Straaten HM, Wester JPJ, De Pont ACJM, Schetz MRC. (2006). Anticoagulation strategies in continuous renal replacement therapy: Can choice be evidence based? Intensive Care Medicine; 134: 188–202.
23. Palsson R, Niles JL. (1999). Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients at high risk of bleeding. Kidney International; 55: 1991–1997.
24. Sackett D, Strauss SE, Richardson W, Rosenberg W, Haynes R. (2000). Evidence Based Medicine: How to Practice and Teach EBM, 2nd edn. New York: Churchill.
25. Swartz R, Pasko D, O’Toole J, Starmann B. (2004).Improving the delivery of continuous renal replacement therapy using citrate anticoagulation. Clinical Nephrology; 61: 134–143.
26. The Cochrane Library (1999-present). http://cochrane.org/(accessed 12/04/08).
27. Van De Wetering J, Westendorp RGJ, Van Der Hoeven JG, Stolk B, Feuth JDM, Chang PC. (1996). Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. Journal of American Society of Nephrology; 7: 145–150.
28. Varhas-Hein O, Von Heymann C, Lipps M, Ziemer S, Ronco C, Neumayer HH, Morgera S, Walte M, Kox WJ, Spies C. (2001). Hirudin versus heparin for anticoagulation in continuous renal replacement therapy. Intensive Care Medicine; 27: 673–679.